LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 43.55 | 84.90 | 1971 | 4287 | 0.4597 | 0.7433 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 43.55 | 84.90 | 54 | 4287 | 0.0126 | -0.0768 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 43.55 | 84.90 | 1578 | 4287 | 0.3680 | 0.6761 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 43.55 | 84.90 | 1951 | 4287 | 0.4550 | 0.7402 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 43.55 | 84.90 | 2003 | 4287 | 0.4671 | 0.7483 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.25 | 84.90 | 9 | 4539 | 0.0020 | -0.3236 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.25 | 84.90 | 2085 | 4539 | 0.4593 | 0.7465 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.25 | 84.90 | 46 | 4539 | 0.0101 | -0.1012 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.25 | 84.90 | 1627 | 4539 | 0.3584 | 0.6726 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.25 | 84.90 | 2067 | 4539 | 0.4553 | 0.7439 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 45.25 | 84.90 | 2097 | 4539 | 0.4619 | 0.7482 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.95 | 84.90 | 17 | 4952 | 0.0034 | -0.2398 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.95 | 84.90 | 2190 | 4952 | 0.4422 | 0.7403 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.95 | 84.90 | 60 | 4952 | 0.0121 | -0.0575 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.95 | 84.90 | 1710 | 4952 | 0.3453 | 0.6684 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.95 | 84.90 | 2125 | 4952 | 0.4291 | 0.7314 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 46.95 | 84.90 | 2159 | 4952 | 0.4359 | 0.7361 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.65 | 84.90 | 22 | 5328 | 0.0041 | -0.2024 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.65 | 84.90 | 2335 | 5328 | 0.4382 | 0.7419 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.65 | 84.90 | 59 | 5328 | 0.0111 | -0.0591 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.65 | 84.90 | 1755 | 5328 | 0.3293 | 0.6606 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.65 | 84.90 | 2266 | 5328 | 0.4252 | 0.7332 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 48.65 | 84.90 | 2304 | 5328 | 0.4324 | 0.7380 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 50.36 | 84.90 | 35 | 5651 | 0.0062 | -0.1361 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 50.36 | 84.90 | 2438 | 5651 | 0.4314 | 0.7408 | MN20160318_Q02 | H19 |